12:00 AM
Oct 22, 2012
 |  BC Week In Review  |  Company News  |  Deals

Iverson Genetic, Johns Hopkins University School of Medicine deal

The university granted Iverson exclusive, worldwide commercialization rights for molecular diagnostics designed to help physicians assess cardiovascular risk in men and women and infertility risk in women....

Read the full 111 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >